Medication info
Empagliflozin 25 mg Tablet

Empagliflozin 25 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Light yellow, oval, biconvex, film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102282 · Approved 2021.03.12 · Insurance code 698504890

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
  • cardiovascular disease
  • occurrence of cardiovascular events
View approved original text

This medication is used in conjunction with dietary and exercise therapy to assist with blood sugar control in adult patients with type 2 diabetes. It can be used as monotherapy, and if blood sugar control is difficult with monotherapy alone, it may be administered in combination with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors such as linagliptin. In particular, for patients with type 2 diabetes who have accompanying cardiovascular disease, refer to professional guidelines regarding the improvement of blood sugar control and impact on the occurrence of cardiovascular events. This medication helps effectively control blood sugar, aiding in the management of diabetes.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Precautions

This medication should not be administered to patients with allergies to the active ingredient or any of the components. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired renal function, those with end-stage kidney disease, or those on dialysis should not take this medication. Since lactose is included in this medication, it should not be administered to patients with genetic problems such as lactose intolerance or galactose intolerance. For patients with mildly impaired renal function, this medication should be given with caution and if renal function continues to deteriorate, dosage should be adjusted or discontinued. Some patients with heart failure have limited experience with this medication, so it should be used cautiously and is not recommended for patients with severe heart failure. When used in conjunction with blood glucose lowering agents such as insulin or sulfonylureas, there is a risk of hypoglycemia; therefore, dosage adjustments of these drugs may be necessary. This medication may cause side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, decreased fluid volume, etc., so caution is advised. Especially in elderly patients or those at risk of fluid volume loss, care should be taken against dehydration and hypotension, and regular monitoring of renal function is important. Serious metabolic abnormalities, such as ketoacidosis, may occur, so immediately inform medical staff if symptoms appear. It is recommended that pregnant or breastfeeding women do not use this medication, and it should be ceased immediately upon confirmation of pregnancy. Safety and efficacy have not been established for children under the age of 18, so it should not be used in this population. No specific toxic reactions have been reported in cases of overdose, but appropriate treatment should be provided according to clinical condition. This medication may interact with other drugs, so if you are taking any other medications, inform your healthcare provider and proceed with caution. Caution is needed while driving or operating machinery due to the risk of hypoglycemia. While taking this medication, pay attention to regular foot care and prevention of genital infections, and consult immediately if there are any abnormal symptoms.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • pruritus
  • rash
  • urticaria
Show 229 more
  • angioedema
  • reduced fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • elevated serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • rectal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • retinal detachment with tear
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the Ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • epigastric pain
  • dental caries
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • passage of blood in stools
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • seborrheic dermatitis
  • dental abscess
  • nasopharyngitis
  • positional vertigo
  • sensory impairment
  • perceptual disturbances
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory abnormalities
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • abnormal electrocardiogram
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vulvovaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • subsequent disease
  • hyperlipidemia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • muscle pain
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • exercise-induced dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • positional dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • shingles
  • dizziness
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes mellitus
  • diabetic retinopathy
  • dry eyes
  • dyspnea
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it is important to store it in a tightly sealed container. Additionally, the medication should be stored at room temperature between 1°C and 30°C, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

Light yellow, oval, biconvex, film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.